Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Circulation

• Publication date

  2000-04-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.CIR.101.13.1586PMID 10747353
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Continuous Monitoring of in Vztro Oxidation of Human Low Density Lipoprotein

  2009cited by this paper
• Angiotensin-(1-7) reduces smooth muscle growth after vascular injury.

  1999cited by this paper
• Comparison of the effects of AT1 receptor blockade and angiotensin converting enzyme inhibition on atherosclerosis.

  1999cited by this paper
• Angiotensin II type 1 receptor-mediated peroxide production in human macrophages.

  1999cited by this paper
• Angiotensin II AT1-receptor blockade inhibits monocyte activation and adherence in transgenic (mRen2)27 rats.

  1999cited by this paper
• Increased angiotensin II type 1 receptor expression in hypercholesterolemic atherosclerosis in rabbits.

  1998cited by this paper
• Evidence that macrophages in atherosclerotic lesions contain angiotensin II.

  1998cited by this paper
• Combination of fosinopril and pravastatin decreases platelet response to thrombin receptor agonist in monkeys.

  1998cited by this paper
• Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease.

  1998cited by this paper
• Delapril slows the progression of atherosclerosis and maintains endothelial function in cholesterol-fed rabbits.

  1998cited by this paper
• Induction of angiotensin converting enzyme and angiotensin II receptors in the atherosclerotic aorta of high-cholesterol fed Cynomolgus monkeys.

  1998cited by this paper
• Phenotypic changes in peripheral blood monocytes of cynomolgus monkeys acutely infected with simian immunodeficiency virus.

  1998cited by this paper
• Short Communication: Phenotypic Changes in Peripheral Blood Monocytes of Cynomolgus Monkeys Acutely Infected with Simian Immunodeficiency Virus

  1998cited by this paper
• The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice.

  1997cited by this paper
• HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia.

  1997cited by this paper
• Restoration of the normal coagulation process: advances in therapies to antagonize heparin.

  1996cited by this paper
• Inhibitory effect of an angiotensin II type 1 receptor antagonist on growth of vascular smooth muscle cells from spontaneously hypertensive rats.

  1996cited by this paper
• Dietary fatty acids, low density lipoprotein composition and oxidation and primate atherosclerosis.

  1996cited by this paper
• Angiotensin II-modified LDL is taken up by macrophages via the scavenger receptor, leading to cellular cholesterol accumulation.

  1996cited by this paper
• Angiotensin II increases monocyte binding to endothelial cells.

  1996cited by this paper
• Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an orally active nonpeptide angiotensin II receptor antagonist, in humans.

  1993cited by this paper
• Angiotensin(1-7) in the spontaneously hypertensive rat.

  1993cited by this paper
• Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit.

  1990cited by this paper
• Atherogenesis during low level hypercholesterolemia in the nonhuman primate. I. Fatty streak formation.

  1990cited by this paper
• Continuous monitoring of in vitro oxidation of human low density lipoprotein.

  1989cited by this paper
• Inhibition of oxidation of methyl linoleate in solution by vitamin E and vitamin C.

  1984cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Angiotensin II and Atherosclerosis: A New Cardiovascular Risk Factor Beyond Hypertension

  2025cites this paper
• Angiotensinogen as a Therapeutic Target for Cardiovascular and Metabolic Diseases.

  2024cites this paper
• Effects of Thymoquinone Alone or in Combination with Losartan on the Cardiotoxicity Caused by Oxidative Stress and Inflammation in Hypercholesterolemia

  2022cites this paper
• Altered Vascular Reactivity to Circulating Angiotensin II in Familial Hypercholesterolemia

  2021cites this paper
• Renin Angiotensin System Blockage by Losartan Neutralize Hypercholesterolemia-Induced Inflammatory and Oxidative Injuries CURRENT

  2020cites this paper
• Renin angiotensin system blockage by losartan neutralize hypercholesterolemia-induced inflammatory and oxidative injuries

  2020cites this paper
• FUNCTIONAL IMPACT OF ANGIOTENSINOGEN SPECIFIC DOMAINS ON ANGIOTENSIN II-MEDIATED FUNCTIONS

  2020cites this paper
• Impact of Advanced Maternal Age on Physiologic Adaptations to Pregnancy in Vervet Monkeys

  2020cites this paper
• SARS-CoV-2/Renin–Angiotensin System: Deciphering the Clues for a Couple with Potentially Harmful Effects on Skeletal Muscle

  2020cites this paper
• Advanced maternal age impacts physiologic adaptations to pregnancy in vervet monkeys

  2020cites this paper
• Advanced maternal age impacts physiologic adaptations to pregnancy in vervet monkeys

  2020cites this paper
• Angiotensin II and leukocyte trafficking: New insights for an old vascular mediator. Role of redox-signaling pathways.

  2020cites this paper
• Effects of angiotensin II receptor blockers in the coronary arteries of hypertensive rats: Analysis of elemental distribution using LEXRF

  2019cites this paper
• Synthesis of drug metal complexes and their influence on human platelet aggregation

  2018cites this paper
• The potential therapeutic use of renin–angiotensin system inhibitors in the treatment of inflammatory diseases

  2018cites this paper
• Dysregulation of the Renin-Angiotensin System and the Vasopressinergic System Interactions in Cardiovascular Disorders

  2018cites this paper
• Simultaneous estimation of Ramipril and Olmesartan Medoximil by RP-HPLC method

  2018cites this paper
• Effects of dietary polyphenols on vascular endothelium and cardiovascular health

  2017cites this paper
• Leukocyte RhoA exchange factor Arhgef1 mediates vascular inflammation and atherosclerosis

  2017cites this paper
• Progress and future opportunities in the development of vaccines against atherosclerosis

  2017cites this paper
• Renin-Angiotensin System and Atherothrombotic Disease

  2017cites this paper
• Dose–Effect of Irbesartan on Cyclooxygenase-2 and Matrix Metalloproteinase-9 Expression in Rabbit Atherosclerosis

  2017cites this paper
• The Different Facets of Dyslipidemia and Hypertension in Atherosclerosis

  2016cites this paper
• A NEW VALIDATED RP-HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF RAMIPRIL AND OLMESARTAN MEDOXOMIL

  2016cites this paper
• Results Ang II Infusion Induces a High Prevalence of WHHL Rabbit Death

  2016cites this paper
• ATRQ&bgr;-001 vaccine prevents atherosclerosis in apolipoprotein E-null mice

  2016cites this paper
• Anti-Inflammatory Therapy in Coronary Artery Disease omparative Effects of AT 1-Antagonism nd Angiotensin-Converting Enzyme Inhibition n Markers of Inflammation and Platelet ggregation in Patients With Coronary Artery Disease

  2016cites this paper
• Angiotensin II Destabilizes Coronary Plaques in Watanabe Heritable Hyperlipidemic Rabbits

  2016cites this paper
• Angiotensin Receptor Blockers Decrease the Risk of Major Adverse Cardiovascular Events in Patients with End-Stage Renal Disease on Maintenance Dialysis: A Nationwide Matched-Cohort Study

  2015cites this paper
• Role of mineralocorticoid receptor antagonists in cardiovascular disease.

  2015cites this paper
• Effects of telmisartan on inflammatory cytokines and coronary plaque component as assessed on integrated backscatter intravascular ultrasound in hypertensive patients.

  2014cites this paper
• Counter-regulatory effects played by the ACE - Ang II - AT1 and ACE2 - Ang-(1-7) - Mas axes on the reactive oxygen species-mediated control of vascular function: perspectives to pharmacological approaches in controlling vascular complications.

  2014cites this paper
• Ferrario and Schiffrin Aldosterone Antagonism in Cardiovascular Disease 207

  2014cites this paper
• Lipid associated biomarkers in patients with systemic lupus erythematosus and rheumatoid arthritis

  2013cites this paper
• REVIEW ON AN ARB HAVING HIGHER ASSOCIATION LOWER DISSOCIATION INDEX FOR A RECEPTOR: A NEW TREND IN ACHIEVEMENT OF HYPERTENSION GOAL

  2013cites this paper
• PHARMACEUTICAL TASTE MASKING TECHNOLOGIES OF BITTER DRUGS: A CONCISE REVIEW

  2013cites this paper
• Contributions of Leukocyte Angiotensin-Converting Enzyme to Development of Atherosclerosis

  2013cites this paper
• Fatty acids, monocytes and ageing

  2013cites this paper
• Role of Cathepsin G in Atherosclerosis

  2013cites this paper
• Comparative effects of different modes of renin angiotensin system inhibition on hypercholesterolaemia‐induced atherosclerosis

  2012cites this paper
• 25 Hydroxy vitamin D3 levels in acute coronary syndrome

  2012cites this paper
• Depletion of Endothelial or Smooth Muscle Cell-Specific Angiotensin II Type 1a Receptors Does Not Influence Aortic Aneurysms or Atherosclerosis in LDL Receptor Deficient Mice

  2012cites this paper
• Losartan

  2012cites this paper
• Effects of ACE-inhibitors and angiotensin receptor blockers on inflammation.

  2012cites this paper
• Role of the renin-angiotensin-aldosterone system in the pathogenesis of atherosclerosis.

  2012cites this paper
• Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Antagonists in Atherosclerosis Prevention

  2012cites this paper
• The renin-angiotensin system in thyroid disorders and its role in cardiovascular and renal manifestations.

  2012cites this paper
• Regulation of AT1R expression through HuR by insulin

  2012cites this paper
• Role of Selective Phospholipase A2 Inhibition in the Treatment of Atherosclerosis

  2012cites this paper
• Papel de la angiotensina II en el proceso aterosclerótico

  2012cites this paper
• EXPRESSION DER KOMPONENTEN DES RENIN- ANGIOTENSIN-SYSTEMS ENTLANG DES MAUSNEPHRONS

  2012cites this paper
• Losartan Attenuates Human Monocyte-derived Dendritic Cell Immune Maturation via Downregulation of Lectin-like Oxidized Low-density Lipoprotein Receptor-1

  2012cites this paper
• Predictors of plaque area for culprit lesion in patients with ischemic heart disease who underwent percutaneous coronary intervention

  2012cites this paper
• Therapeutic effect of pentoxifylline versus losartan on experimentally induced acute pancreatitis in adult albino rats: light and electron microscopic study

  2011cites this paper
• Multifunctional actions of approved and candidate stroke drugs

  2011cites this paper
• Pleiotropic effects of ARB in vascular metabolism--focusing on atherosclerosis-based cardiovascular disease.

  2011cites this paper
• Telmisartan Exerts Antiatherosclerotic Effects by Activating Peroxisome Proliferator-Activated Receptor-&ggr; in Macrophages

  2011cites this paper
• Thiazolidinedione‐independent activation of peroxisome proliferator‐activated receptor γ is a potential target for diabetic macrovascular complications

  2011cites this paper
• Prevention of accelerated atherosclerosis by AT1 receptor blockade in experimental renal failure.

  2011cites this paper
• [Inflammation and atherosclerosis: the role of Renin-Angiotensin system and its inhibition].

  2010cites this paper
• Lack of regression of left ventricular hypertrophy is associated with higher incidence of revascularization in hypertension: The LIFE Study

  2010cites this paper
• Valsartan alleviates atherosclerotic lesions in pulmonary arteries of rabbits via an endothelium-dependent mechanism

  2010cites this paper
• ASSOCIATION 0 F ANGIOTENSIN CONVERTING ENZYME GENE INSERTION / DELETION POLYMORPHISM WITH CORONARY ARTERY DISEASE IN SOUTH INDIAN POPULATION

  2010cites this paper
• Differential expression of protein kinase C isoforms in coronary arteries of diabetic mice lacking the G-protein Gα11

  2010cites this paper
• Have the Renin-Angiotensin-Aldosterone System Perturbations in Cardiovascular Disease Been Exhausted?

  2010cites this paper
• Regulation of Cardiovascular Control Mechanisms by Angiotensin-(1–7) and Angiotensin-Converting Enzyme 2

  2010cites this paper
• Are there effects of renin-angiotensin system antagonists beyond blood pressure control?

  2010cites this paper
• Genetic and molecular determinants of atherosclerotic plaque instability.

  2010cites this paper
• Simultaneous Estimation of Ramipril and Telmisartan in Tablet Dosage Form by Spectrophotometry

  2010cites this paper
• Aliskiren: beyond blood pressure reduction

  2010influential citation
• Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis.

  2010cites this paper
• Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7).

  2010cites this paper
• The effect of the expression of angiotensin II on extracellular matrix metalloproteinase inducer (EMMPRIN) in macrophages is mediated via the AT1/COX-2/PGE2 pathway

  2010cites this paper
• UNIVERSIDADE FEDERAL DE OURO PRETO NÚCLEO DE PESQUISAS EM CIÊNCIAS BIOLÓGICAS PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS BIOLÓGICAS

  2010influential citation
• Impact of olmesartan on blood pressure, endothelial function, and cardiovascular outcomes

  2010cites this paper
• Molecular mechanisms of irbesartan suppressing atherosclerosis in high cholesterol-diet apolipoprotein E knock-out mice.

  2010cites this paper
• Chymase as an important target for preventing complications of metabolic syndrome.

  2010cites this paper
• Bloqueio do sistema renina-angiotensina atenua lesões em órgãos-alvo em modelo de diabetes mellitus tipo 2 e hipercolesterolemia induzidos por dieta

  2009cites this paper
• Effect of renin angiotensin system inhibition on cardiovascular sequelae in elderly hypertensive patients with insulin resistance

  2009cites this paper
• Treatment of Hypertension in Metabolic Syndrome Subjects with Amlodipine and Olmesartan—Effects on Oxidized Non-Esterified Free Fatty Acids and Cytokine Production

  2009cites this paper
• Nitric Oxide, NAD(P)H Oxidase, and Atherosclerosis

  2009cites this paper
• Effect of angiotensin receptor blockade on endothelial function: focus on olmesartan medoxomil

  2009cites this paper
• Losartan Metabolite EXP3179 Blocks NADPH Oxidase-Mediated Superoxide Production by Inhibiting Protein Kinase C: Potential Clinical Implications in Hypertension

  2009cites this paper
• Chronic Treatment With Losartan Results in Sufficient Serum Levels of the Metabolite EXP3179 for PPAR&ggr; Activation

  2009cites this paper
• Inhibition of Tumor Necrosis Factor-α–Induced Interleukin-6 Expression by Telmisartan Through Cross-Talk of Peroxisome Proliferator-Activated Receptor-γ With Nuclear Factor &kgr;B and CCAAT/Enhancer-Binding Protein-β

  2009cites this paper
• The Effect of Telmisartan on Endothelial Function and Arterial Stiffness in Patients With Essential Hypertension

  2009cites this paper
• Neointimal-specific induction of apoptosis by losartan results in regression of vascular lesion in rat aorta.

  2009cites this paper
• The Renin-Angiotensin System Modulates Inflammatory Processes in Atherosclerosis: Evidence from Basic Research and Clinical Studies

  2009cites this paper
• Attenuation of inflammation and expansive remodeling by Valsartan alone or in combination with Simvastatin in high-risk coronary atherosclerotic plaques.

  2009cites this paper
• Cyclooxygenase and prostaglandin synthases: roles in plaque stability and instability in humans

  2009cites this paper
• Update on therapeutic strategies to increase adiponectin function and secretion in metabolic syndrome

  2009cites this paper
• Effect of angiotensin receptor blockade on endothelial function: focus on olmesartan medoxomil

  2009cites this paper
• Pleiotropic effects of drugs inhibiting the renin-angiotensin-aldosterone system.

  2009cites this paper
• Are the pleiotropic effects of telmisartan clinically relevant?

  2009cites this paper
• Shear Stress Regulates Angiotensin Type 1 Receptor Expression in Endothelial Cells

  2009cites this paper
• Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors

  2009cites this paper
• Insulin Resistance and Cardiovascular Disease

  2008cites this paper
• ACE-inhibitor, AT1-receptor-antagonist, or both? A clinical pharmacologist`s perspective after publication of the results of ONTARGET

  2008cites this paper
• Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice.

  2008cites this paper
• Role of bone marrow renin-angiotensin system in the pathogenesis of atherosclerosis.

  2008cites this paper